Nicolas Fuséri

2.0k total citations · 1 hit paper
12 papers, 1.6k citations indexed

About

Nicolas Fuséri is a scholar working on Immunology, Oncology and Organic Chemistry. According to data from OpenAlex, Nicolas Fuséri has authored 12 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 4 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in Nicolas Fuséri's work include Immune Cell Function and Interaction (11 papers), T-cell and B-cell Immunology (8 papers) and Immunotherapy and Immune Responses (4 papers). Nicolas Fuséri is often cited by papers focused on Immune Cell Function and Interaction (11 papers), T-cell and B-cell Immunology (8 papers) and Immunotherapy and Immune Responses (4 papers). Nicolas Fuséri collaborates with scholars based in France, United States and Australia. Nicolas Fuséri's co-authors include Éric Vivier, Julie Chaix, Thierry Walzer, Claude Roth, Laura Chiossone, Marc Dalod, Mathieu Bléry, Pascale André, François Romagné and Kasper Hoebe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Nicolas Fuséri

12 papers receiving 1.6k citations

Hit Papers

Maturation of mouse NK cells is a 4-stage developmental p... 2009 2026 2014 2020 2009 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Maturation of mouse NK cells is a 4-stage developmental program
    2009 601 citations Laura Chiossone, Julie Chaix et al. Blood profile →

Peers

Nicolas Fuséri
Erwan Corcuff France
Anna Pessino Italy
Naoto Matsuki United States
Noah Tubo United States
Jeff Martinson United States
Jean‐Paul Rivals Switzerland
Russell B. Foxall Portugal
Aurore Fenis France
Kristine Murphy United States
Luigia Morelli Italy
Erwan Corcuff France
Nicolas Fuséri
Citations per year, relative to Nicolas Fuséri Nicolas Fuséri (= 1×) peers Erwan Corcuff

Countries citing papers authored by Nicolas Fuséri

Since Specialization
Citations

This map shows the geographic impact of Nicolas Fuséri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Fuséri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Fuséri more than expected).

Fields of papers citing papers by Nicolas Fuséri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Fuséri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Fuséri. The network helps show where Nicolas Fuséri may publish in the future.

Co-authorship network of co-authors of Nicolas Fuséri

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Fuséri. A scholar is included among the top collaborators of Nicolas Fuséri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Fuséri. Nicolas Fuséri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Sola, Caroline, Thomas Arnoux, Fabien Chanuc, et al.. (2016). Abstract 2342: NKG2A immune checkpoint blockade enhances the anti-tumor efficacy of PD1/PD-L1 inhibitors in a preclinical model. Cancer Research. 76(14_Supplement). 2342–2342. 2 indexed citations
2.
Sola, Caroline, Mathieu Bléry, Cécile Bonnafous, et al.. (2014). Lirilumab Enhances Anti-Tumor Efficacy of Elotuzumab. Blood. 124(21). 4711–4711. 8 indexed citations
3.
Kohrt, Holbrook E., Ariane Thielens, Aurélien Marabelle, et al.. (2013). Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies. Blood. 123(5). 678–686. 229 indexed citations
4.
Sola, Caroline, Fabien Chanuc, Ariane Thielens, et al.. (2013). Abstract 493: Antitumoral efficacy of therapeutic human anti-KIR antibody (BMS-986015/IPH2102) in a preclinical xenograft tumor model.. Cancer Research. 73(8_Supplement). 493–493. 1 indexed citations
5.
Kohrt, Holbrook E., Ariane Thielens, Aurélien Marabelle, et al.. (2013). Anti-KIR Antibody Enhancement Of Anti-Lymphoma Activity Of Natural Killer Cells As Monotherapy and In Combination With Anti-CD20 Antibodies. Blood. 122(21). 4417–4417. 12 indexed citations
6.
Sola, Caroline, Fabien Chanuc, Ariane Thielens, et al.. (2013). Anti-tumoral efficacy of therapeutic human anti-KIR antibody (Lirilumab/BMS-986015/IPH2102) in a preclinical xenograft tumor model. Journal for ImmunoTherapy of Cancer. 1(Suppl 1). P40–P40. 6 indexed citations
7.
Chiossone, Laura, Julie Chaix, Nicolas Fuséri, et al.. (2010). Maturation of Mouse NK Cells is a Four-stage Developmental Program. Clinical Immunology. 135. S48–S48. 2 indexed citations
8.
Chiossone, Laura, Julie Chaix, Nicolas Fuséri, et al.. (2009). Maturation of mouse NK cells is a 4-stage developmental program. Blood. 113(22). 5488–5496. 601 indexed citations breakdown →
9.
Sola, Caroline, Pascale André, Céline Lemmers, et al.. (2009). Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo. Proceedings of the National Academy of Sciences. 106(31). 12879–12884. 54 indexed citations
10.
Chaix, Julie, Marlowe S. Tessmer, Kasper Hoebe, et al.. (2008). Cutting Edge: Priming of NK Cells by IL-18. The Journal of Immunology. 181(3). 1627–1631. 257 indexed citations
11.
Walzer, Thierry, Mathieu Bléry, Julie Chaix, et al.. (2007). Identification, activation, and selectivein vivoablation of mouse NK cells via NKp46. Proceedings of the National Academy of Sciences. 104(9). 3384–3389. 359 indexed citations
12.
Chiesa, Sabrina, Michaël Mingueneau, Nicolas Fuséri, et al.. (2005). Multiplicity and plasticity of natural killer cell signaling pathways. Blood. 107(6). 2364–2372. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erwan Corcuff Breakdown of academic impact, for papers by Anna Pessino Breakdown of academic impact, for papers by Naoto Matsuki Breakdown of academic impact, for papers by Noah Tubo Breakdown of academic impact, for papers by Jeff Martinson Breakdown of academic impact, for papers by Jean‐Paul Rivals Breakdown of academic impact, for papers by Russell B. Foxall Breakdown of academic impact, for papers by Aurore Fenis Breakdown of academic impact, for papers by Kristine Murphy Breakdown of academic impact, for papers by Luigia Morelli
Rankless by CCL
2026